Single Stock Futures at Prop Firms

The accessible retail prop firm model — Topstep, Apex Trader Funding, My Funded Futures and similar — is built around CME index futures and their micros. The staple instruments are the E-mini and Micro E-mini S&P 500 (ES/MES) and Nasdaq-100 (NQ/MNQ), along with other index, commodity, and rate futures. These markets are centralized, deeply liquid, and well suited to the drawdown-based evaluation rules these firms run.

Single stock futures are a different, newly listed product. Even though they trade on the same CME Globex platform, a prop firm has to explicitly add each contract to its tradable instrument list, set margins, and fold it into risk management before funded traders can touch it. As of the launch, that broad support does not yet exist across the major firms.

CME only launched single stock futures on July 27, 2026. New instruments typically take time to appear on prop firm platforms: the firm and its technology/clearing providers must support the contracts, risk teams must model how single-stock volatility behaves under evaluation rules, and the firm must decide whether the product fits its business.

Single-stock exposure also behaves differently from an index. A single name can gap violently on earnings or company-specific news, which is harder to manage under fixed trailing-drawdown rules than a diversified index future. That risk profile makes some firms cautious about adding single-stock products quickly. It is realistic to expect a gradual, selective rollout — if it happens — rather than day-one support everywhere.

The only reliable source of truth is each firm's published list of tradable instruments and its rulebook — not marketing or forum rumor. Look specifically for the SSF symbols (standard and micro) in the allowed-products list inside the trading platform or the firm's documentation. If they are not explicitly listed, assume they are not permitted, since trading a disallowed instrument can void an evaluation or payout.

Also check the platform and data feed: a firm can only offer SSFs if its platform (for example, tools in the NinjaTrader or Tradovate ecosystem) exposes the contracts with live CME data. Watch too for news/earnings rules — some firms restrict holding through high-impact single-stock events — and how micro vs standard contracts count against risk limits. When in doubt, ask the firm's support directly before trading.

If SSFs do arrive at prop firms, they will trade under the same evaluation mechanics as other futures — a profit target and a maximum (often trailing) drawdown — but the risk character is different. A single stock can move on an earnings surprise, a downgrade, or a headline in a way a broad index rarely does, so overnight and event risk is more concentrated.

That concentration argues for smaller size and tighter risk on single-name contracts than you might use on an index micro. The micro SSF (10 shares) would be the natural tool for keeping risk contained on an evaluation account. Treat any single-stock position as higher-variance and size it so a single adverse gap cannot breach your drawdown.

It is plausible that some prop firms add single stock futures over time, given they already run on CME futures infrastructure and traders are asking. But that is an expectation, not a promise — as of this writing, broad SSF support at the major retail futures prop firms is not established, and we cannot point to a confirmed, funded SSF offering. Do not sign up for a challenge assuming SSFs are available.

If trading single stock futures on a funded account is your specific goal, verify current instrument lists before paying for any evaluation, and be prepared that the answer today may be no. In the meantime, index futures remain the proven path for prop firm funding. This is educational information, not financial advice; prop trading and leveraged futures both carry substantial risk of loss.